News: June, 2013

Next Page »

20 Years

Thursday, June 27th, 2013

Over its 20 years, Vanderbilt-Ingram Cancer Center has grown and multiplied and grown some more, spreading into all parts of the University. It introduced new programs and resources, involving more and more scientists and clinicians and cultivating the highest level patient care, research and education. So much has changed in 20 years—mapping the human genome, [...]

Thursday, June 27th, 2013

Signature Strengths

Thursday, June 27th, 2013

I opened my lab in the Cancer Center at Vanderbilt on St. Patrick’s Day in 1995, and remember thinking what a “lucky” date to move into a lab. I never imagined that 12 years later I would be leading one of the nation’s premier cancer centers. When I was asked to be interim director in [...]

Lighting Up Cancer Cells

Thursday, June 27th, 2013

Two urologic surgeons at Vanderbilt-Ingram Cancer Center are among a leading group of cancer physicians using an innovative new imaging agent and blue light system to “light up” cancerous cells inside the bladder. The combined system is used to confirm non-invasive papillary cancer inside the bladder and help surgeons detect and remove more of the [...]

Inhibiting COX-2

Thursday, June 27th, 2013

One of the most promising cancer prevention targets to emerge in the 1990s was the enzyme cyclooxygenase-2 (COX-2). Raymond Dubois, M.D., Ph.D., and his lab were the first in the world to report that COX-2 expression is elevated in human colorectal cancers and that inhibitors of the enzyme block the growth of colorectal cancer cells [...]

News from Around the Cancer Center

Thursday, June 27th, 2013

Arteaga to lead American Association for Cancer Research Carlos Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt, has been elected president-elect of the American Association for Cancer Research for 2013-2014. Elected by the organization’s members, Arteaga will work with the AACR board of directors and the 34,000-plus membership to further the AACR’s mission [...]

Recent Publications by VICC Researchers

Thursday, June 27th, 2013

Vanderbilt-Ingram Cancer Center is committed to conducting innovative, high-impact, basic, translational and clinical research with the greatest potential for making a difference for cancer patients, today and in the future. Here’s a sampling of work published in peer-reviewed journals by Cancer Center investigators in 2012-2013: Long-term effects of prostate therapies tracked A new study published [...]

What does it mean to be a Comprehensive Cancer Center?

Thursday, June 27th, 2013

Comprehensive Cancer Center is the highest ranking awarded by the National Cancer Institute, one of the National Institutes of Health and the nation’s foremost authority on cancer. NCI-designated cancers centers are institutions dedicated to research in the development of more effective approaches to prevention, diagnosis and treatment of cancer. Of the 67 NCI-designated cancer centers, [...]

Power of the People

Thursday, June 27th, 2013

Population-based studies provide answers to critical questions about the prevention of cancer and other diseases. VICC manages three large population-based prospective cohort studies with more than 225,000 participants. The Southern Community Cohort Study (SCCS), initiated in 2001 and supported by Caterpillar Inc., has enrolled more than 86,000 participants in 12 states. It seeks to answer [...]

Cancer’s Jekyll and Hyde

Thursday, June 27th, 2013

When Hal Moses, M.D., and his colleagues at the Mayo Clinic first described and purified a “transforming growth factor” in the early 1980s, they had no idea what they were about to unleash. Today, TGF-beta touches every part of cancer biology. The TGF-beta signaling pathway regulates cell growth and proliferation and is altered in several [...]